Orforglipron is an oral, non-peptide glucagon-like peptide-1 receptor agonist under clinical investigation for type 2 diabetes. It is a complex polycyclic compound with multiple aromatic rings and heterocycles, used as an active pharmaceutical ingredient in research.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 2212020-52-3
Orforglipron hemicalcium hydrate
pharmaceutical raw material
AOD 9604
pharmaceutical raw material
Olanzapine pamoate hydrate
pharmaceutical raw material
25-hydroxy-7-dehydrocholesterol
pharmaceutical raw material
Dexketoprofen
pharmaceutical raw material
3-[(1S,2S)-1-[5-[(4S)-2,2-dimethyloxan-4-yl]-2-[(4S)-2-(4-fluoro-3,5-dimethylphenyl)-3-[3-(4-fluoro-1-methylindazol-5-yl)-2-oxoimidazol-1-yl]-4-methyl-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carbonyl]indol-1-yl]-2-methylcyclopropyl]-4H-1,2,4-oxadiazol-5-one
USUWIEBBBWHKNI-KHIFEHGGSA-N
C[C@H]1C[C@]1(C2=NOC(=O)N2)N3C4=C(C=C(C=C4)[C@H]5CCOC(C5)(C)C)C=C3C(=O)N6CCC7=NN(C(=C7[C@@H]6C)N8C=CN(C8=O)C9=C(C1=C(C=C9)N(N=C1)C)F)C1=CC(=C(C(=C1)C)F)C